Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 16:2:29445.
doi: 10.3402/ecrj.v2.29445. eCollection 2015.

Expert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung disease

Anders Løkke  1 , Lars Ahlbeck  2 , Leif Bjermer  3 , Jann Mortensen  4   5 , Anders Østrem  6 , Iris Pasternack  7 , Guilherme Safioti  8 , Saku Torvinen  9
Affiliations

Expert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung disease

Anders Løkke et al. Eur Clin Respir J. .

Abstract

The effective self-management of obstructive lung disease is dependent upon the patient achieving good inhaler technique. However, many current inhalers are complicated to use, which may lead to handling difficulties. These difficulties can cause clinically relevant errors, whereby pharmacotherapy fails to achieve adequate lung deposition and therapeutic effect. In this report, the potential of novel inhaler devices to overcome unmet needs in the management of obstructive lung disease is considered by a panel of Nordic experts. The panel concludes that innovative inhalers can contribute to good disease management and better use of healthcare resources.

Keywords: COPD; access; asthma; choice; cost; dry powder inhaler; economic; innovation; medication errors; metered dose inhaler; obstructive lung disease; outcome; patient compliance; patient preference; price; reimbursement; substitution.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Optimal clinical efficacy is dependent on both drug and device innovations.
See this image and copyright information in PMC

References

    1. European Respiratory Society. The burden of lung disease. European lung white book. 2013. Available from: http://www.erswhitebook.org/files/public/Chapters/01_burden.pdf [cited 10 November 2015].
    1. Fabricius P, Løkke A, Marott JL, Vestbo J, Lange P. Prevalence of COPD in Copenhagen. Respir Med. 2011;105:410–7. - PubMed
    1. Socialstyrelsen. De nationella riktlinjerna för vård vid astma och kroniskt obstruktiv lungsjukdom (KOL) Available from: http://www.socialstyrelsen.se/riktlinjer/nationellariktlinjer/nationella... [cited 10 November 2015].
    1. To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204. - PMC - PubMed
    1. Gulsvik A, Boman G, Dahl R, Gislason T, Nieminen M. The burden of obstructive lung disease. Respir Med. 2006;100(Suppl. 1):S2–9.